KR890001543A - 당뇨병 치료제 - Google Patents
당뇨병 치료제 Download PDFInfo
- Publication number
- KR890001543A KR890001543A KR1019880008404A KR880008404A KR890001543A KR 890001543 A KR890001543 A KR 890001543A KR 1019880008404 A KR1019880008404 A KR 1019880008404A KR 880008404 A KR880008404 A KR 880008404A KR 890001543 A KR890001543 A KR 890001543A
- Authority
- KR
- South Korea
- Prior art keywords
- diabetes treatment
- group
- diabetes
- integer
- note
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (1)
- 활성 성분으로서 다음 일반식(I)의 화합물 또는 약제학적으로 무독한 이의 염을 함유함을 특징으로 하는 당뇨병 치료제상기 식에서, R은 이미다졸릴 그룹, 티아졸릴 그룹 또는 피리딜 그룹을 나타내고, n은 1 또는 2를 나타내며, m은 1 내지 4의 정수를 나타낸다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16948687 | 1987-07-07 | ||
| JP62-169486 | 1987-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR890001543A true KR890001543A (ko) | 1989-03-27 |
Family
ID=15887423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880008404A KR890001543A (ko) | 1987-07-07 | 1988-07-07 | 당뇨병 치료제 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4942171A (ko) |
| EP (1) | EP0298465B1 (ko) |
| KR (1) | KR890001543A (ko) |
| AU (1) | AU609835B2 (ko) |
| CA (1) | CA1314224C (ko) |
| DE (1) | DE3878494T2 (ko) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5506219A (en) * | 1988-08-29 | 1996-04-09 | E. R. Squibb & Sons, Inc. | Pyridine anchors for HMG-CoA reductase inhibitors |
| IL91542A0 (en) * | 1988-10-06 | 1990-04-29 | Erba Carlo Spa | N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them |
| JP4974463B2 (ja) | 2002-12-20 | 2012-07-11 | ニツポネツクス・インコーポレーテツド | インダン酢酸誘導体ならびに製薬学的薬剤としてのそれらの使用、中間体及び製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| US4766127A (en) * | 1987-02-10 | 1988-08-23 | Syntex (U.S.A.) Inc. | 2-(3-pyridylmethyl)naphthalene-6-carboxylic acid as a thromboxane synthetase inhibitor |
-
1988
- 1988-07-05 CA CA000571151A patent/CA1314224C/en not_active Expired - Fee Related
- 1988-07-06 EP EP88110813A patent/EP0298465B1/en not_active Expired - Lifetime
- 1988-07-06 US US07/215,488 patent/US4942171A/en not_active Expired - Fee Related
- 1988-07-06 DE DE8888110813T patent/DE3878494T2/de not_active Expired - Fee Related
- 1988-07-07 KR KR1019880008404A patent/KR890001543A/ko not_active Application Discontinuation
- 1988-07-07 AU AU18822/88A patent/AU609835B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US4942171A (en) | 1990-07-17 |
| AU1882288A (en) | 1989-01-12 |
| AU609835B2 (en) | 1991-05-09 |
| DE3878494T2 (de) | 1993-06-03 |
| DE3878494D1 (de) | 1993-03-25 |
| EP0298465A3 (en) | 1990-08-01 |
| EP0298465A2 (en) | 1989-01-11 |
| CA1314224C (en) | 1993-03-09 |
| EP0298465B1 (en) | 1993-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910011896A (ko) | 신규한 글리코펩티드 유도체 | |
| KR900003163A (ko) | 시클로헥산 유도체 | |
| KR927003525A (ko) | 술폰아닐리드 유도체 및 의약 | |
| KR930703292A (ko) | 신규 퀴놀론 유도체 또는 그의 염 및 이 화합물을 함유하는 항균제 | |
| KR910004191A (ko) | 신질환치료제 | |
| KR920016089A (ko) | 제i형 당뇨병의 치료방법 | |
| KR890008136A (ko) | 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체 | |
| KR890000009A (ko) | 농업용 생리활성제 | |
| KR910021361A (ko) | 항궤양 물질 | |
| KR890001540A (ko) | 심부전증 치료제 | |
| KR930701170A (ko) | 항당뇨병약품 | |
| KR890001543A (ko) | 당뇨병 치료제 | |
| KR900701262A (ko) | 췌장염 등에 대한 치료제 | |
| KR870006035A (ko) | 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법 | |
| KR980002033A (ko) | 트리아졸 유도체 또는 그 염 | |
| KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
| KR960702458A (ko) | 퀴놀린 유도체 또는 그의 염 및 이를 함유 하는 항균제 | |
| KR890014101A (ko) | 동맥경화증 치료제 | |
| KR880009644A (ko) | 궤양성 대장질환 치료용 약한 조성물 | |
| KR910000645A (ko) | 개선된 경련치료제 | |
| KR900017587A (ko) | 바이러스 감염증 치료제의 제조를 위한 티아졸 유도체 티프로티모드의 용도 | |
| KR910002853A (ko) | 도파민 효능제 | |
| KR900016130A (ko) | 2-피리딜메틸티오 유도체 및 궤양 치료제 | |
| KR910000148A (ko) | 말초순환 장애용 치료제 | |
| KR890009270A (ko) | 식물 보호용 살균제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |